Incidence, 30-day readmission rates and predictors of readmission after new onset atrial fibrillation who underwent transcatheter aortic valve replacement

Transcatheter aortic valve replacement (TAVR) has been increasingly utilized as an intervention for the management of symptomatic intermediate and high risk severe aortic stenosis, and utilization rates are expected to increase exponentially worldwide.1,2 One of the most frequent complication of TAVR is the development of New-onset Atrial Fibrillation (NOAF), with an estimated incidence ranging from 16% to 51.1%.3 NOAF corresponds to the detection of atrial fibrillation (AF) during or after the TAVR procedure in a patient without previously known AF.

Source: Heart and Lung - November 3, 2019 Category: Intensive Care Authors: Rajkumar Doshi, Sailaja Pisipati, Mohamed Taha, Mihir Dave, Jay Shah, Devina Adalja, Nageshwara Gullapalli Source Type: research